##gff-version 3
##sequence-region O43272 1 600
O43272	UniProtKB	Modified residue	368	368	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9WU79	
O43272	UniProtKB	Modified residue	486	486	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9WU79	
O43272	UniProtKB	Alternative sequence	1	108	.	.	.	ID=VSP_021848;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
O43272	UniProtKB	Alternative sequence	1	84	.	.	.	ID=VSP_040848;Note=In isoform 3. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:10192398,ECO:0000303|PubMed:9385373;Dbxref=PMID:10192398,PMID:9385373	
O43272	UniProtKB	Alternative sequence	85	95	.	.	.	ID=VSP_040849;Note=In isoform 3. LLARHEQLLYV->MLEFVMREWKK;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:10192398,ECO:0000303|PubMed:9385373;Dbxref=PMID:10192398,PMID:9385373	
O43272	UniProtKB	Natural variant	8	8	.	.	.	ID=VAR_064883;Note=P->L	
O43272	UniProtKB	Natural variant	19	19	.	.	.	ID=VAR_064884;Note=Polymorphism%3B moderate reduction of enzymatic activity. Q->P;Dbxref=dbSNP:rs2008720	
O43272	UniProtKB	Natural variant	30	30	.	.	.	ID=VAR_064885;Note=P->S	
O43272	UniProtKB	Natural variant	58	58	.	.	.	ID=VAR_064886;Note=A->T	
O43272	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_029563;Note=Polymorphism%3B may be a risk factor for schizophrenia%3B moderate reduction of enzymatic activity. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15662599;Dbxref=PMID:15662599	
O43272	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_029564;Note=Polymorphism%3B mild decrease of enzymatic activity. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15662599;Dbxref=PMID:15662599	
O43272	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_029565;Note=Polymorphism%3B moderate reduction of enzymatic activity. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15662599;Dbxref=dbSNP:rs4819756,PMID:15662599	
O43272	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_029874;Note=T->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17135275;Dbxref=PMID:17135275	
O43272	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_029566;Note=In HYRPRO1%3B mild decrease of enzymatic activity. L->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12217952,ECO:0000269|PubMed:15662599;Dbxref=PMID:12217952,PMID:15662599	
O43272	UniProtKB	Natural variant	406	406	.	.	.	ID=VAR_029567;Note=In SCZD4%3B may be associated with disease susceptibility%3B strongly reduced enzymatic activity. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11891283,ECO:0000269|PubMed:15662599;Dbxref=dbSNP:rs3970555,PMID:11891283,PMID:15662599	
O43272	UniProtKB	Natural variant	426	426	.	.	.	ID=VAR_029568;Note=In HYRPRO1%3B moderate reduction of enzymatic activity. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15662599;Dbxref=PMID:15662599	
O43272	UniProtKB	Natural variant	427	427	.	.	.	ID=VAR_029569;Note=In HYRPRO1 and SCZD4%3B may be associated with disease susceptibility%3B moderate reduction of enzymatic activity. V->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11891283,ECO:0000269|PubMed:15662599;Dbxref=dbSNP:rs2238731,PMID:11891283,PMID:15662599	
O43272	UniProtKB	Natural variant	431	431	.	.	.	ID=VAR_029570;Note=In HYRPRO1%3B moderate reduction of enzymatic activity. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12217952,ECO:0000269|PubMed:15662599,ECO:0000269|PubMed:17135275;Dbxref=dbSNP:rs2904552,PMID:12217952,PMID:15662599,PMID:17135275	
O43272	UniProtKB	Natural variant	441	441	.	.	.	ID=VAR_029571;Note=In HYRPRO1 and SCZD4%3B may be associated with disease susceptibility%3B strongly reduced enzymatic activity. L->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11891283,ECO:0000269|PubMed:12217952,ECO:0000269|PubMed:15662599;Dbxref=dbSNP:rs2904551,PMID:11891283,PMID:12217952,PMID:15662599	
O43272	UniProtKB	Natural variant	444	444	.	.	.	ID=VAR_029875;Note=G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17135275;Dbxref=PMID:17135275	
O43272	UniProtKB	Natural variant	453	453	.	.	.	ID=VAR_029572;Note=In HYRPRO1 and SCZD4%3B may be associated with disease susceptibility%3B strongly reduced enzymatic activity. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11891283,ECO:0000269|PubMed:12217952,ECO:0000269|PubMed:15662599;Dbxref=dbSNP:rs3970559,PMID:11891283,PMID:12217952,PMID:15662599	
O43272	UniProtKB	Natural variant	455	455	.	.	.	ID=VAR_029573;Note=In HYRPRO1%3B mild decrease of enzymatic activity. A->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12217952,ECO:0000269|PubMed:15662599;Dbxref=dbSNP:rs1807467,PMID:12217952,PMID:15662599	
O43272	UniProtKB	Natural variant	466	466	.	.	.	ID=VAR_029574;Note=In SCZD4%3B may be associated with disease susceptibility%3B strongly reduced affinity for FAD%3B strongly reduced enzymatic activity. T->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11891283,ECO:0000269|PubMed:15662599;Dbxref=dbSNP:rs2870984,PMID:11891283,PMID:15662599	
O43272	UniProtKB	Natural variant	472	472	.	.	.	ID=VAR_029575;Note=In HYRPRO1 and SCZD4%3B associated with disease susceptibility%3B mild decrease of enzymatic activity. A->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11891283,ECO:0000269|PubMed:12217952,ECO:0000269|PubMed:15662599;Dbxref=dbSNP:rs2870983,PMID:11891283,PMID:12217952,PMID:15662599	
O43272	UniProtKB	Natural variant	488	488	.	.	.	ID=VAR_036566;Note=In a breast cancer sample%3B somatic mutation. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
O43272	UniProtKB	Natural variant	521	521	.	.	.	ID=VAR_029576;Note=Strongly reduced enzymatic activity. Q->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15662599;Dbxref=PMID:15662599	
O43272	UniProtKB	Natural variant	521	521	.	.	.	ID=VAR_029577;Note=In HYRPRO1 and SCZD4%3B may be associated with disease susceptibility%3B enhanced enzymatic activity. Q->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11891283,ECO:0000269|PubMed:12217952,ECO:0000269|PubMed:15489334,ECO:0000269|PubMed:15662599;Dbxref=dbSNP:rs450046,PMID:11891283,PMID:12217952,PMID:15489334,PMID:15662599	
O43272	UniProtKB	Sequence conflict	144	144	.	.	.	Note=Y->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O43272	UniProtKB	Sequence conflict	164	164	.	.	.	Note=T->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O43272	UniProtKB	Sequence conflict	343	343	.	.	.	Note=P->H;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O43272	UniProtKB	Sequence conflict	347	347	.	.	.	Note=R->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O43272	UniProtKB	Sequence conflict	455	456	.	.	.	Note=AE->Q;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O43272	UniProtKB	Sequence conflict	571	571	.	.	.	Note=L->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O43272	UniProtKB	Sequence conflict	588	588	.	.	.	Note=R->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O43272	UniProtKB	Sequence conflict	596	596	.	.	.	Note=F->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
